Every material Form 8-K Protolabs filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Proto Labs reported third quarter 2024 revenue of $125.6 million, down 3.9% from $130.7 million a year earlier, with GAAP diluted earnings of $0.29 per share versus $0.31. It also gave a fourth quarter 2024 revenue outlook of $115 million to $123 million and GAAP diluted EPS of $0.10 to $0.18. For shareholders, the headline revenue and profit measures both declined year over year, and the company said it generated $24.8 million in operating cash flow in the quarter.
Q3 2024 revenue was $125.6 million, down 3.9% from $130.7 million in Q3 2023.
Q3 2024 GAAP net income was $7.2 million, or $0.29 per diluted share, versus $8.0 million, or $0.31, a year earlier.
Q3 2024 Adjusted EBITDA was $21.9 million, or 17.4% of revenue, versus $23.9 million, or 18.3%, in Q3 2023.
Q4 2024 outlook: revenue of $115 million to $123 million and GAAP diluted EPS of $0.10 to $0.18.
On October 21, 2024, Proto Labs' board approved a plan to close its prototype injection molding facility in Eschenlohe, Germany, and discontinue Direct Metal Laser Sintering 3D printing services at its Putzbrunn, Germany facility. The company expects total restructuring charges of $4.5 million to $6.0 million and cash expenditures of $3.0 million to $4.0 million, mostly for severance, and says it will keep offering manufacturing services across Europe through internal facilities and partners.
Board approved the plan on October 21, 2024, closing the Eschenlohe injection molding facility and discontinuing 3D printing services at Putzbrunn, Germany.
Total restructuring charges expected at $4.5 million to $6.0 million, including $2.5 million to $3.5 million in severance and $2.0 million to $2.5 million in facility write-downs.
About $4.0 million of the charge expected in the fourth quarter of 2024; total cash expenditures expected at $3.0 million to $4.0 million.
Plan expected to be substantially complete within the next year.
Proto Labs disclosed a settlement agreement with Bjoern Klaas, former Vice President and General Manager of the EMEA region, who left his role in July 2024. His termination date will be November 30, 2024, and he will receive severance, bonus, and equity vesting terms. The filing describes a departure of a former officer, not a change in company leadership or financial results.
Settlement Agreement dated October 1, 2024 among Proto Labs, Proto Labs Germany GmbH and Bjoern Klaas
Termination date set for November 30, 2024
Base salary severance of EUR 299,792, equal to one times annualized base salary
Company waived Klaas' non-compete and non-solicitation obligations and will pay half of his base salary for one year
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Protolabs filing is on SEC EDGAR ↗. 8-K briefs of other companies →